CLINICAL_TRIALS
trial_result
· 2017-11-30
Clinical Trial Update: The Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical Cord [NA]
Summary
The update reports a dose-escalation safety study to determine the maximum tolerated dose of umbilical cord-derived mesenchymal stem cells for knee osteoarthrit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Knee Osteoarthritis, Umbilical Cord Bleeding | NA | Status: UNKNOWN